122 related articles for article (PubMed ID: 14974920)
1. Fibrous bodies are associated with lower GH production and decreased expression of E-cadherin in GH-producing pituitary adenomas.
Nishioka H; Haraoka J; Akada K
Clin Endocrinol (Oxf); 2003 Dec; 59(6):768-72. PubMed ID: 14974920
[TBL] [Abstract][Full Text] [Related]
2. Significance of immunohistochemical expression of Rab3B and SNAP-25 in growth hormone-producing pituitary adenomas.
Nishioka H; Haraoka J
Acta Neuropathol; 2005 Jun; 109(6):598-602. PubMed ID: 15895198
[TBL] [Abstract][Full Text] [Related]
3. Tissue kallikrein and the effect of bromocriptine in human prolactin and growth hormone-secreting pituitary adenomas.
Jones TH; Figueroa CD; Smith CM; Bhoola KD
Agents Actions Suppl; 1992; 38 ( Pt 2)():175-82. PubMed ID: 1462825
[TBL] [Abstract][Full Text] [Related]
4. Comparison of growth hormone-producing and non-growth hormone-producing pituitary adenomas: imaging characteristics and pathologic correlation.
Hagiwara A; Inoue Y; Wakasa K; Haba T; Tashiro T; Miyamoto T
Radiology; 2003 Aug; 228(2):533-8. PubMed ID: 12819334
[TBL] [Abstract][Full Text] [Related]
5. Down-regulation of E-cadherin and catenins in human pituitary growth hormone-producing adenomas.
Sano T; Rong QZ; Kagawa N; Yamada S
Front Horm Res; 2004; 32():127-32. PubMed ID: 15281343
[TBL] [Abstract][Full Text] [Related]
6. In vitro short-term effects of SMS 201-995, bromocriptine and TRH on growth hormone cell morphology from human pituitary adenomas.
García García J; Jiménez Reina L; García Luna PP; Leal Cerro A; Astorga Jiménez R; García García-Revillo J; Bernal Valls G
Histol Histopathol; 1989 Apr; 4(2):223-33. PubMed ID: 2520459
[TBL] [Abstract][Full Text] [Related]
7. Pathological study of thyrotropin-secreting pituitary adenoma: plurihormonality and medical treatment.
Teramoto A; Sanno N; Tahara S; Osamura YR
Acta Neuropathol; 2004 Aug; 108(2):147-53. PubMed ID: 15185102
[TBL] [Abstract][Full Text] [Related]
8. Diagnosis of pituitary adenomas on touch preparations assisted by immunocytochemistry.
Kontogeorgos G; Bassiouka I; Giannou P; Vamvassakis E; Rologis D; Orphanidis G
Acta Cytol; 1995; 39(2):141-52. PubMed ID: 7887060
[TBL] [Abstract][Full Text] [Related]
9. Mixed growth hormone- and prolactin cell adenomas of the pituitary gland. An immunoelectron microscopic study.
Holm R; Nesland JM; Attramadal A; Reinli S; Johannessen JV
J Submicrosc Cytol Pathol; 1989 Apr; 21(2):339-50. PubMed ID: 2752363
[TBL] [Abstract][Full Text] [Related]
10. Growth hormone-producing pituitary adenomas: correlations between clinical characteristics and morphology.
Yamada S; Aiba T; Sano T; Kovacs K; Shishiba Y; Sawano S; Takada K
Neurosurgery; 1993 Jul; 33(1):20-7. PubMed ID: 7689191
[TBL] [Abstract][Full Text] [Related]
11. Downregulation of E-cadherin and its undercoat proteins in pituitary growth hormone cell adenomas with prominent fibrous bodies.
Xu B; Sano T; Yoshimoto K; Yamada S
Endocr Pathol; 2002; 13(4):341-51. PubMed ID: 12665652
[TBL] [Abstract][Full Text] [Related]
12. Fibrous bodies in growth hormone-secreting adenomas contain cytokeratin filaments.
Neumann PE; Goldman JE; Horoupian DS; Hess MA
Arch Pathol Lab Med; 1985 Jun; 109(6):505-8. PubMed ID: 2581522
[TBL] [Abstract][Full Text] [Related]
13. Pituitary adenomas: serum hormone levels and immunohistochemical staining for ACTH, GH and prolactin.
Herzog T; Schlote W; Lorenz R; Jungmann E; Althoff PH
Clin Neuropathol; 1993; 12(2):117-20. PubMed ID: 8386600
[TBL] [Abstract][Full Text] [Related]
14. Expression of glycoprotein hormones and intracytoplasmic distribution of cytokeratin in growth hormone-producing pituitary adenomas.
Sano T; Ohshima T; Yamada S
Pathol Res Pract; 1991 Jun; 187(5):530-3. PubMed ID: 1717959
[TBL] [Abstract][Full Text] [Related]
15. [Immunohistochemistry for pituitary hormones and Ki-67 in growth hormone producing pituitary adenomas].
Brito J; Sáez L; Lemp M; Liberman C; Michelsen H; Araya AV
Rev Med Chil; 2008 Jul; 136(7):831-6. PubMed ID: 18949157
[TBL] [Abstract][Full Text] [Related]
16. Clinicopathological features of growth hormone-producing pituitary adenomas: difference among various types defined by cytokeratin distribution pattern including a transitional form.
Obari A; Sano T; Ohyama K; Kudo E; Qian ZR; Yoneda A; Rayhan N; Mustafizur Rahman M; Yamada S
Endocr Pathol; 2008; 19(2):82-91. PubMed ID: 18629656
[TBL] [Abstract][Full Text] [Related]
17. Pituitary adenoma in Carney complex: an immunohistochemical, ultrastructural, and immunoelectron microscopic study.
Kurtkaya-Yapicier O; Scheithauer BW; Carney JA; Kovacs K; Horvath E; Stratakis CA; Vidal S; Vella A; Young WF; Atkinson JL; Lloyd RV; Kontogeorgos G
Ultrastruct Pathol; 2002; 26(6):345-53. PubMed ID: 12537759
[TBL] [Abstract][Full Text] [Related]
18. The long-term efficacy of conventional radiotherapy in patients with GH-secreting pituitary adenomas.
Minniti G; Jaffrain-Rea ML; Osti M; Esposito V; Santoro A; Solda F; Gargiulo P; Tamburrano G; Enrici RM
Clin Endocrinol (Oxf); 2005 Feb; 62(2):210-6. PubMed ID: 15670198
[TBL] [Abstract][Full Text] [Related]
19. Expression and significance of E-cadherin and β-catenins in pituitary adenoma.
Zhou K; Jin H; Luo Y
Int J Surg Pathol; 2013 Aug; 21(4):363-7. PubMed ID: 23349466
[TBL] [Abstract][Full Text] [Related]
20. Growth hormone receptor mRNA expression in non-functioning and somatotroph pituitary adenomas: implications for growth hormone substitution therapy?
Beuschlein F; Hancke K; Petrick M; Göbel H; Honegger J; Reincke M
Exp Clin Endocrinol Diabetes; 2005 Apr; 113(4):214-8. PubMed ID: 15891957
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
